TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-0.56 Insider Own1.28% Shs Outstand1.11B Perf Week12.20%
Market Cap8.91B Forward P/E3.17 EPS next Y2.61 Insider Trans-2.73% Shs Float1.10B Perf Month-18.66%
Income-615.00M PEG- EPS next Q0.54 Inst Own45.50% Short Float1.54% Perf Quarter-2.47%
Sales15.56B P/S0.57 EPS this Y110.30% Inst Trans0.11% Short Ratio1.84 Perf Half Y-10.97%
Book/sh8.44 P/B0.98 EPS next Y4.81% ROA-1.30% Target Price10.18 Perf Year-21.59%
Cash/sh2.02 P/C4.10 EPS next 5Y2.00% ROE-6.10% 52W Range7.23 - 11.55 Perf YTD3.37%
Dividend- P/FCF15.24 EPS past 5Y39.70% ROI4.50% 52W High-28.13% Beta1.21
Dividend %- Quick Ratio0.70 Sales past 5Y-6.20% Gross Margin49.80% 52W Low14.76% ATR0.38
Employees37037 Current Ratio1.10 Sales Q/Q-8.10% Oper. Margin3.70% RSI (14)47.59 Volatility3.99% 4.71%
OptionableYes Debt/Eq2.45 EPS Q/Q- Profit Margin-4.00% Rel Volume0.57 Prev Close8.28
ShortableYes LT Debt/Eq2.23 EarningsMay 03 BMO Payout- Avg Volume9.16M Price8.30
Recom2.90 SMA20-0.25% SMA50-4.74% SMA200-6.70% Volume4,882,846 Change0.21%
May-17-22Upgrade BofA Securities Underperform → Neutral $9
May-04-22Downgrade Piper Sandler Neutral → Underweight $11 → $7
Apr-05-22Upgrade Barclays Equal Weight → Overweight $11 → $13
Mar-25-22Upgrade Bernstein Mkt Perform → Outperform $11
Jan-27-22Downgrade Argus Buy → Hold
Oct-28-21Downgrade Raymond James Outperform → Mkt Perform
May-04-21Downgrade UBS Buy → Neutral $15 → $11
Apr-07-21Resumed RBC Capital Mkts Sector Perform $11
Nov-25-20Initiated Oppenheimer Perform
Aug-06-20Upgrade Barclays Underweight → Equal Weight $10 → $13
Jul-27-20Resumed Goldman Neutral $12
Jun-01-20Upgrade SunTrust Hold → Buy
Apr-24-20Resumed Citigroup Neutral $10
Apr-06-20Upgrade UBS Neutral → Buy $14 → $12
Feb-24-20Downgrade Edward Jones Hold → Sell
Nov-12-19Upgrade JP Morgan Underweight → Neutral $8
Oct-17-19Upgrade Gabelli & Co Hold → Buy
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
May-17-22 01:49PM  
09:10AM  
08:00AM  
07:45AM  
May-12-22 08:00AM  
May-11-22 08:51AM  
May-10-22 03:10PM  
08:00AM  
May-06-22 10:30PM  
May-05-22 04:35PM  
May-04-22 11:07AM  
May-03-22 04:58PM  
04:07PM  
11:00AM  
10:36AM  
08:59AM  
07:42AM  
07:31AM  
07:11AM  
07:00AM  
May-02-22 03:55PM  
08:00AM  
Apr-28-22 05:21AM  
Apr-26-22 06:42PM  
Apr-25-22 04:11PM  
02:25PM  
09:00AM  
Apr-21-22 09:05AM  
Apr-20-22 11:14AM  
06:17AM  
Apr-19-22 05:15PM  
Apr-05-22 02:55PM  
12:03PM  
07:34AM  
Apr-04-22 04:05PM  
10:55AM  
06:00AM  
Apr-01-22 08:00AM  
Mar-30-22 12:04PM  
11:26AM  
10:18AM  
09:38AM  
09:16AM  
09:09AM  
Mar-26-22 07:31AM  
Mar-25-22 02:18PM  
04:10AM  
Mar-22-22 12:16PM  
06:00AM  
Mar-21-22 04:01PM  
03:36PM  
02:55PM  
Mar-17-22 02:19PM  
Mar-14-22 06:00AM  
Mar-11-22 11:09AM  
Mar-07-22 08:00AM  
Mar-02-22 07:33AM  
Feb-28-22 06:06AM  
Feb-16-22 06:20PM  
Feb-14-22 05:11PM  
Feb-10-22 11:43AM  
03:00AM  
Feb-09-22 04:11PM  
08:02AM  
07:40AM  
07:19AM  
Feb-08-22 03:22PM  
Feb-07-22 02:16PM  
10:35AM  
10:12AM  
Feb-03-22 05:33PM  
Feb-01-22 08:00AM  
Jan-31-22 10:30AM  
Jan-24-22 09:30AM  
Jan-20-22 09:06AM  
Jan-19-22 05:36AM  
Jan-18-22 04:24PM  
04:22PM  
03:50PM  
08:00AM  
Jan-17-22 12:05PM  
Jan-14-22 12:22PM  
Jan-04-22 01:35PM  
Jan-03-22 06:22AM  
05:06AM  
Dec-30-21 05:20PM  
04:38PM  
01:44PM  
01:29PM  
01:27PM  
12:04PM  
12:00PM  
05:51AM  
04:52AM  
Dec-29-21 09:21AM  
07:50AM  
Dec-22-21 04:30PM  
Dec-16-21 02:38PM  
09:31AM  
08:31AM  
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell S.A. to develop mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fridriksdottir HafrunExecutive VP, Global R&DMay 17Sale8.22130,0001,068,0671,387May 19 07:31 AM
Dethlefs SvenEVP, North America CommercialMar 07Sale7.376,99351,515165,381Mar 08 04:04 PM
Daniell RichardExec. VP, European CommercialMar 07Sale7.3722,576166,31143,182Mar 08 04:03 PM
Drape EricExecutive VP Global OperationsMar 07Sale7.3711,33483,49478,072Mar 08 04:05 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 07Sale7.378,94165,866126,087Mar 08 04:07 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 07Sale7.379,05766,72061,137Mar 08 04:13 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 04Sale7.4823,254173,99842,311Mar 08 04:13 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale7.4824,638184,35498,977Mar 08 04:07 PM
Drape EricExecutive VP Global OperationsMar 04Sale7.4823,458175,52461,191Mar 08 04:05 PM
Daniell RichardExec. VP, European CommercialMar 04Sale7.4836,376272,18320,280Mar 08 04:03 PM
Dethlefs SvenEVP, North America CommercialMar 04Sale7.483,90429,212147,422Mar 08 04:04 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 28Sale8.146,45252,53321,380Mar 02 07:54 AM
Shani EliEVP,Global Marketing&PortfolioFeb 28Sale8.145,31143,2439,091Mar 02 07:53 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 28Sale8.147,59061,79965,509Mar 02 07:47 AM
Drape EricExecutive VP Global OperationsFeb 28Sale8.149,79779,76945,830Mar 02 07:45 AM
Dethlefs SvenEVP, North America CommercialFeb 28Sale8.144,86239,58799,457Mar 02 07:43 AM
Daniell RichardExec. VP, European CommercialFeb 28Sale8.1420,598167,71320,280Mar 02 07:41 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 09Sale9.066,11055,3589,402Feb 10 04:13 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 09Sale9.066,11655,41251,417Feb 10 04:09 PM
Drape EricExecutive VP Global OperationsFeb 09Sale9.063,58332,46436,113Feb 10 04:08 PM
Dethlefs SvenEVP, North America CommercialFeb 09Sale9.064,13837,49186,973Feb 10 04:06 PM
Daniell RichardExec. VP, European CommercialFeb 09Sale9.0613,135119,01020,280Feb 10 04:05 PM
Fridriksdottir HafrunExecutive VP, Global R&DAug 10Sale9.9550,860506,02141,412Aug 12 04:04 PM
Drape EricExecutive VP Global OperationsMay 21Sale11.0140,000440,32033,128May 25 08:41 AM